DSIP (Delta Sleep-Inducing Peptide) Clinics in the United States

What Is DSIP?

DSIP (Delta Sleep-Inducing Peptide) is a neuropeptide that promotes deep, slow-wave (delta) sleep by interacting with specific receptors in the brain's sleep regulation centers. It was first isolated from the cerebral venous blood of rabbits in 1977 and has been studied for its broad regulatory effects on the nervous and endocrine systems.

Beyond sleep induction, DSIP has demonstrated stress-protective effects, modulation of corticotropin release, antioxidant properties, and has been investigated for its role in reducing withdrawal symptoms from alcohol and opioids. It produces natural sleep without the sedation or dependence associated with pharmaceutical sleep aids.

It is administered via subcutaneous injection before bed.

Who Considers DSIP?

• Adults with insomnia or poor sleep quality not responding to standard interventions
• People seeking natural, non-pharmaceutical sleep support
• Those with high-stress lifestyles experiencing cortisol-related sleep disruption
• Patients in recovery programs seeking sleep normalization without sedatives

What to Expect at a Consultation

Consultations for DSIP include a review of sleep history, contributing factors (stress, hormones, lifestyle), and an assessment of prior sleep interventions. It is often used alongside other sleep and recovery protocols and may be combined with other peptides as part of a comprehensive approach.